Melanoma C32 ENU resistance to Combination Therapy

ABSTRACT: This study involves mutagenizing C32, a melanoma cell line, with ENU to identify those mutations which engender resistance to a targeted treatment.

PROVIDER: EGAS00001001614 | EGA |

REPOSITORIES: EGA